APOE and amyloidosis: APOE has long been known for its role in modulating AD and CAA risk (depending on the combination of the three human isoforms APOE2, APOE3 and APOE4) and for its ability to bind Aβ peptides and to be recruited to amyloid deposits (Yu et al., 2014).